Sonic Healthcare Limited

SHL

AU000000SHL7

Healthcare Facilities & Services

Market Closed - Australian S.E. Other stock markets 02:10:46 2024-05-10 am EDT			5-day change	1st Jan Change
26.76 ^AUD	+0.60%		+2.45%	-16.58%

Apr. 23	Microba's Revenue Climbs 297% in Fiscal Q3	MT
Mar. 20	Sonic Healthcare Limited agreed to acquire Dr. Risch Shared Services Ag for CHF 117 million.	CI

Sonic Healthcare Limited Appoints Suzanne Crowe as Director

April 06, 2020 at 02:30 am EDT

Sonic Healthcare Limited appointed Suzanne Crowe as Director, effective April 6, 2020.

Latest news about Sonic Healthcare Limited

Microba's Revenue Climbs 297% in Fiscal Q3	Apr. 23	MT
Sonic Healthcare Limited agreed to acquire Dr. Risch Shared Services Ag for CHF 117 million.	Mar. 19	CI
Sonic Healthcare Signs Binding Agreement to Acquire Swiss Medical Lab Group Dr Risch	Mar. 19	MT
Sonic Healthcare to Pay $132 Million for Swiss Lab Group	Mar. 19	DJ
Proteomics Says PromarkerD's US Launch Delayed	Mar. 19	MT
Sonic Healthcare Subsidiary Signs NHS Pathology Contract in UK	Mar. 15	MT
Sonic Healthcare's UK Subsidiary Signs Pathology Services Contract with NHS	Mar. 14	MT
Microba Life Sciences Rise 9% Following Launch of MetaPanel Test With Sonic Healthcare	Mar. 12	MT
Morgan Stanley Adjusts Sonic Healthcare’s Price Target to AU$33.60 From AU$35.55, Keeps at Overweight	Mar. 05	MT
Australian shares skid off record highs to end lower; GDP data awaited	Mar. 04	RE
Jarden Research Adjusts Sonic Healthcare’s Price Target to AU$28.88 From AU$31.20, Keeps at Neutral	Feb. 20	MT
Sonic Healthcare Shares Fall 6% as Profit Slips, Revenue Rises 5.5% in H1 FY24	Feb. 19	MT
Transcript : Sonic Healthcare Limited, H1 2024 Earnings Call, Feb 20, 2024	Feb. 19
Sonic Healthcare 1st Half Net Profit Falls 47%	Feb. 19	DJ
Sonic Healthcare Posts 5.5% Rise in H1 FY24 Revenue, Profit Slips	Feb. 19	MT
Sonic Healthcare Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 19	CI
Sonic Healthcare Limited completed the acquisition of Pathology Watch Inc. for $150 million.	Jan. 30	CI
Sonic Healthcare Acquiring Pathology Watch for $130 Million; Shares Down 5%	Nov. 15	MT
Transcript : Sonic Healthcare Limited - Shareholder/Analyst Call	Nov. 15
Sonic Healthcare Agrees US$150 Million Acquisition of Pathology Watch	Nov. 15	DJ
Australian shares rise on gold, healthcare boost; RBA meeting in focus	Nov. 05	RE
Microba Life Sciences' Domestica, International Personal Testing Revenue Rises in Fiscal Q1	23-10-19	MT
Australia's CSL tanks as Novo Nordisk's kidney trial success stokes competition concerns	23-10-12	RE
Sonic Healthcare Limited completed the acquisition of Diagnosticum Gmbh.	23-10-01	CI
Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on 21 September, 2023	23-08-16	CI

Chart Sonic Healthcare Limited

Duration

Period

More charts

Sonic Healthcare Limited is an Australia-based healthcare provider. The Company is engaged in laboratory medicine / pathology, radiology, and primary care medical services, across operations in Australia, Europe, and North America. The Company operates through three segments: Laboratory, Radiology and Other. The Laboratory segment provides pathology/clinical laboratory services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, and Belgium. The Radiology segment provides diagnostic imaging services in Australia. The Radiology technologies include Magnetic resonance imaging (MRI), Computed tomography (CT), Ultrasound, X-ray, Mammography, and others. The Other segment includes medical center operations (IPN), occupational health services (Sonic HealthPlus), and other minor operations. The Company's provides services to clinicians, hospitals, community health services, and their patients. The Company has more than 120 radiology centers.

Sector

Healthcare Facilities & Services

Calendar

2024-08-21 - Q4 2024 Earnings Call

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Ratings for Sonic Healthcare Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

26.76 AUD

Average target price

30.63 AUD

Spread / Average Target

+14.45%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-16.58%	8.49B
RADNET, INC.	+58.90%	4.08B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-39.78%	2.42B
SYNLAB AG	-10.33%	2.42B
DR. LAL PATHLABS LIMITED	-8.91%	2.33B
NEOGENOMICS, INC.	-2.53%	2.01B
FLEURY S.A.	-19.90%	1.53B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-38.30%	1.26B
METROPOLIS HEALTHCARE LIMITED	+2.19%	1.07B
NOVOGENE CO., LTD.	-34.96%	868M

Medical & Diagnostic Laboratories